MONDAY, Jan. 27, 2025 -- For patients with overweight or obesity and type 2 diabetes, dapagliflozin plus regular calorie restriction is associated...
Vous n'êtes pas connecté
Researchers at the University of Liverpool have found that the weight loss drug, Tirzepatide is associated with significantly reduced risk of developing Type 2 diabetes (T2D). Obesity is a major worldwide health concern. Current global estimates of the number of adults living with obesity is at 650m, with a further 340m children and adolescents. Overweight […]
MONDAY, Jan. 27, 2025 -- For patients with overweight or obesity and type 2 diabetes, dapagliflozin plus regular calorie restriction is associated...
Obesity is a growing health concern worldwide, especially for older adults. Carrying excess weight does more than change how we look—it has serious...
Findings indicate that dapagliflozin and calorie restriction together improve weight loss and metabolic health, increasing the likelihood of diabetes...
A diet inspired by non-industrialized societies can lower risks of obesity, diabetes, and heart disease. Researchers plan to share recipes with the...
TUESDAY, Jan. 21, 2025 -- For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced...
TUESDAY, Jan. 21, 2025 -- For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced...
A recent study suggests that metformin, a widely prescribed medication for type 2 diabetes, may reduce the risk of developing certain types of skin...
Tirzepatide helps adults lose up to 20% of their weight, reducing sleep apnea interruptions by 25 per hour, with 50% symptom-free in a year.
A team of international researchers, led by the University of Exeter, has discovered a new cause of why people who lack a specific blood group are...
Researchers at UT Southwestern Medical Center have identified a gene called OTP that plays a critical role in controlling hunger and body weight. This...